Our client, a leading provider of analytical laboratory instruments and software, engaged MarketsandMarkets to grow revenues. We offered in-depth intelligence into the interconnected ecosystem of our client, client’s clients, and their clients. Our team defined and solved a series of problems for tapping into new opportunities identified. Few of the key problems solved during the engagement are:
We leveraged our AI-driven market intelligence platform, KnowledgeStore, for identifying key technologies used in biomarker identification and profiling. Our team further identified key applications and diseases where each of these technologies is used. We interviewed a host of product suppliers and potential customers/end-use industries to understand their unmet needs, possible use cases, and benefits from these technologies as well as what they looked for in a technology partner.
Our analysts expanded the understanding of the market potential across various application areas, including clinical diagnostics, research, and drug discovery. Further, we also helped the client to build an understanding of the competitive landscape, varying business models, and strategies of different players in the biomarker technology market. Our client services team helped the client to devise a differentiated product offering and forge suitable alliances to help them win in this market.
Revenue Shifts Identified
Presently there is an increasing focus on identification of new cancer biomarkers. Checkpoint inhibitors have the fastest growth rate among all the available drug classes against cancer. However, PD1 and L1 are no considered more sufficient. Microsatellite instability (MSI) and deficient MisMatch Repair (dMMR) are now trending. Ongoing research efforts are focusing on understanding potential life-threatening toxicities.
Long-term goals are focused towards development and application of high-dimensional antigen-specific T cell profiling technology; finding novel therapeutic targets such as tumor-derived microvesicles, soluble immune proteins, and metabolites; discovery of more accurate biomarkers of clinical outcomes; and prediction of immune response to Immuno-Oncology (IO) therapies. Owing to this there will be many collaborations/joint clinical efforts between pharma/biopharma and molecular diagnostics provider companies.
The industry is also focusing on CAR-T Cells, Next Generation ADCs, combination strategies to target new biomarkers and tap cohort of patients who are non-responsive to immunotherapies. As the vast majority of cancer deaths are the result of these cells forming new tumors resistant to the drugs, the industry is also trying to overcome resistance of various combinations.
Revenue Impact (RI)
Our insights helped the global leader in the analytical laboratory solutions market to identify new revenue sources in biomarker industry valued at USD 55 million by 2025.
See how future revenue sources change for these companies
Our client, a leading provider of analytical laboratory instruments and software, engaged MarketsandMarkets to grow revenues. We offered in-depth intelligence into the i ....Read More
One of the leading players in the power supply market, engaged MarketsandMarkets to secure and grow revenue streams. We offered detailed intelligence into the shifting r ....Read More
A leading vendor of professional cleaning robots engaged MarketsandMarkets to grow and secure revenue streams. For this purpose, our team offered detailed insights into ....Read More
Our client, a UK-based medical device manufacturing company, wanted to grow its revenues. For this purpose, our team offered actionable insights into the interconnection ....Read More
Our client, a leading provider of analytical laboratory instruments and software, engaged MarketsandMarkets to grow its revenues. Our team offered in-depth intelligence ....Read More
The client, a leading healthcare company, was interested in growing revenues. Our team offered detailed insights on the opportunities in the hemodialysis and peritoneal ....Read More
Our client, a dental implant manufacturer based in Asia, wanted to grow its revenues. We offered in-depth intelligence into the connected ecosystems of our client, clien ....Read More
Our client, a nonprofit biomedical research institute, was keen on building a substantive business from in-vivo toxicology testing services in North America and Europe. ....Read More
Our client, one of the key players in the therapeutic apheresis market, engaged MarketsandMarkets to grow revenues. We defined and solved a series of problems for the cl ....Read More
Our client engaged MarketsandMarkets to grow revenues. For this purpose, we offered insights into the market value of 6mV single-photon radiotherapy systems in developin ....Read More
The client, a leading player in the neonatal critical care devices and breast pump market, was keen to strengthen its market position and grow revenues. For this purpos ....Read More
Our client, a top-20 global antimicrobial susceptibility testing market leader, engaged MarketsandMarkets to secure revenue streams. Our team offered a comprehensive vie ....Read More
Our client, a top-ten global technology infrastructure leader, was keen on increasing its revenues. It engages MarketsandMarkets for insights and roadmap to secure new g ....Read More
Our client engaged MarketsandMarkets to increase its revenues. For this purpose, we offered insights into the shifting revenue sources of client’s clients and their clie ....Read More
Our client, a key provider of hernia repair surgery, engaged MarketsandMarkets to increase revenues and identify growth opportunities. The client was keen on understandi ....Read More
Our client, an emerging medical device company, was planning to grow its revenues with the launch of an innovative CO2 monitoring device in the US. It engaged Marketsand ....Read More
Our client, a leading global healthcare company that specializes in lifesaving medicines and technologies for infusion, transfusion, and clinical nutrition, engaged Mark ....Read More